David Valcárcel

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Esperanza Such, Ulrich Germing, Luca Malcovati et al. · Blood · 2013 · 317 citations · Full text

Medicine, Hematology, Oncology +13

Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

David Valcárcel, Rodrigo Martino, Dolores Caballero et al. · Journal of Clinical Oncology · 2007 · 234 citations

Medicine, Hematology, Immunology +16

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Carmen Canals, R. Arranz et al. · Haematologica · 2011 · 213 citations · Full text

Medicine, Immunology, Oncology +17

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

José Antonio Pérez‐Simón, Olga López‐Villar, Enrique J. Andreu et al. · Haematologica · 2011 · 174 citations · Full text

Pharmacy, Clinical Sciences, Cell Therapy +13

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Uwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini et al. · The Lancet · 2023 · 164 citations · Full text

Medicine, Hematology, Pharmacology +14